Stock listing
Aquis:6MKD Merck & Company, Inc. Share Price
UK listing (Aquis) of Merck & Company, Inc. · home listing NYSE:MRK
Follow Merck & Company, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:MRK
$149.52 USD +3.19 (+2.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:MRK
- Day range
- $147.40 – $151.35 USDOct 30, 2026
- Volume
- 12.34M sharesOct 30, 2026
- Market cap
- $368.9B USDAt the close on Oct 30, 2026 · price × 2.47B shares outstanding
- 52-week range
- $82.01 – $156.92 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.49B USDMedian day 8.99M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:MRK · Home | $149.52 USD | +3.19 (+2.2%) | 12,343,143 | $149.55 | $151.35 | $147.40 | $146.33 | Close on Oct 30, 2026 |
| BCBA:MRK | $49,660 ARS | +1,480 (+3.1%) | 5,049 | $49,660 | $50,100 | $48,940 | $48,180 | Close on Oct 30, 2026 |
| Xetra:6MK | €127.72 EUR | -1.50 (-1.2%) | 486 | €126.48 | €127.94 | €125.88 | €129.22 | Close on Oct 27, 2026 |
| BMV:MRK | $2,653.00 MXN | -55.00 (-2.0%) | 222 | $2,652.00 | $2,653.00 | $2,652.00 | $2,708.00 | Close on Oct 27, 2026 |
| B3:MRCK34 | 94.35 BRL | +3.89 (+4.3%) | 12,517 | 94.26 | 95.39 | 93.37 | 90.46 | Close on Oct 27, 2026 |
| TSX:MRK | $31.51 CAD | -0.74 (-2.3%) | 5,518 | $31.34 | $31.59 | $31.14 | $32.25 | Close on Oct 27, 2026 |
| Cboe Canada:MRK | $31.50 CAD | -0.70 (-2.2%) | 3,100 | $31.54 | $31.54 | $31.47 | $32.20 | Close on Oct 27, 2026 |
| Frankfurt:6MK | €134.60 EUR | +6.72 (+5.3%) | — | €132.28 | €134.60 | €132.28 | €127.88 | Close on Oct 30, 2026 |
| LSE:0QAH | $141.84 USD | -3.14 (-2.2%) | 14,731 | $139.80 | $142.70 | $139.00 | $144.98 | Close on Oct 27, 2026 |
| VIE:MRK | €127.60 EUR | -1.58 (-1.2%) | — | €126.22 | €127.60 | €126.22 | €129.18 | Close on Oct 27, 2026 |
| Dusseldorf:6MK | €132.00 EUR | +5.82 (+4.6%) | — | €132.00 | €132.00 | €132.00 | €126.18 | Close on Oct 30, 2026 |
| Hamburg:6MK | €133.98 EUR | +6.32 (+5.0%) | — | €132.20 | €133.98 | €132.10 | €127.66 | Close on Oct 30, 2026 |
| Munich:6MK | €127.56 EUR | -2.90 (-2.2%) | 40 | €126.54 | €127.56 | €126.54 | €130.46 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:MRK · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $149.52 | +3.19 | +2.2% | $149.55 | $151.35 | $147.40 | 12,343,143 | |
| $146.33 | +5.40 | +3.8% | $144.62 | $149.26 | $143.32 | 13,444,048 | |
| $140.93 | -0.89 | -0.6% | $140.00 | $142.40 | $139.21 | 8,237,980 | |
| $141.82 | +1.21 | +0.9% | $140.22 | $142.69 | $139.83 | 9,057,185 | |
| $140.61 | -4.66 | -3.2% | $145.89 | $146.61 | $139.93 | 13,092,210 | |
| $145.27 | -1.97 | -1.3% | $145.02 | $145.44 | $143.41 | 8,379,846 | |
| $147.24 | -2.64 | -1.8% | $151.05 | $154.02 | $144.07 | 19,026,525 | |
| $149.88 | +1.58 | +1.1% | $147.11 | $150.00 | $147.11 | 9,006,934 | |
| $148.30 | +4.67 | +3.3% | $146.29 | $149.36 | $146.12 | 9,922,119 | |
| $143.63 | -2.32 | -1.6% | $145.00 | $147.41 | $143.53 | 10,447,763 | |
| $145.95 | +0.76 | +0.5% | $146.96 | $147.80 | $145.61 | 11,230,634 | |
| $145.19 | -2.18 | -1.5% | $149.70 | $152.34 | $144.91 | 13,865,460 | |
| $147.37 | +5.39 | +3.8% | $143.10 | $148.16 | $142.66 | 9,807,791 | |
| $141.98 | -3.47 | -2.4% | $145.85 | $145.93 | $141.58 | 8,379,646 | |
| $145.45 | -0.15 | -0.1% | $145.75 | $146.36 | $144.64 | 8,019,256 | |
| $145.60 | +3.22 | +2.3% | $141.37 | $146.68 | $141.36 | 9,288,746 | |
| $142.38 | -0.41 | -0.3% | $141.90 | $142.77 | $138.89 | 8,411,488 | |
| $142.79 | +0.85 | +0.6% | $142.03 | $144.15 | $141.49 | 6,353,502 | |
| $141.94 | +2.40 | +1.7% | $140.13 | $142.16 | $139.74 | 8,073,204 | |
| $139.54 | -4.76 | -3.3% | $143.67 | $144.06 | $138.80 | 9,485,736 | |
| $144.30 | +0.49 | +0.3% | $143.77 | $144.35 | $142.73 | 9,661,871 | |
| $143.81 | -1.50 | -1.0% | $144.71 | $145.39 | $143.26 | 7,859,758 | |
| $145.31 | -3.97 | -2.7% | $148.95 | $149.27 | $145.26 | 10,230,770 | |
| $149.28 | +0.59 | +0.4% | $148.17 | $150.36 | $146.09 | 8,203,975 | |
| $148.69 | -0.09 | -0.1% | $147.65 | $149.19 | $146.28 | 7,700,986 | |
| $148.78 | +0.80 | +0.5% | $148.06 | $149.98 | $147.48 | 8,292,483 | |
| $147.98 | -0.10 | -0.1% | $148.17 | $151.46 | $147.90 | 10,312,770 | |
| $148.08 | -2.83 | -1.9% | $151.32 | $152.01 | $146.89 | 9,703,729 | |
| $150.91 | +1.41 | +0.9% | $148.69 | $153.57 | $148.04 | 11,173,540 | |
| $149.50 | +2.63 | +1.8% | $146.79 | $150.49 | $145.60 | 7,996,433 | |
| $146.87 | -0.28 | -0.2% | $147.08 | $147.84 | $145.74 | 31,159,670 | |
| $147.15 | +2.24 | +1.5% | $145.74 | $147.65 | $145.32 | 11,063,790 | |
| $144.91 | +1.12 | +0.8% | $143.96 | $144.97 | $143.50 | 7,230,927 | |
| $143.79 | -1.06 | -0.7% | $143.85 | $144.15 | $142.32 | 8,292,750 | |
| $144.85 | +0.92 | +0.6% | $146.42 | $147.09 | $144.10 | 7,414,159 | |
| $143.93 | -0.78 | -0.5% | $145.52 | $145.90 | $143.68 | 8,678,200 | |
| $144.71 | -2.82 | -1.9% | $147.94 | $148.00 | $144.10 | 7,542,000 | |
| $147.53 | -0.93 | -0.6% | $148.96 | $149.41 | $147.18 | 8,546,000 | |
| $148.46 | -1.87 | -1.2% | $148.41 | $149.60 | $146.28 | 11,187,000 | |
| $150.33 | -2.01 | -1.3% | $150.83 | $152.22 | $150.09 | 4,395,400 | |
| $152.34 | +0.70 | +0.5% | $152.80 | $152.80 | $148.90 | 6,498,300 | |
| $151.64 | +1.78 | +1.2% | $151.50 | $152.69 | $149.97 | 8,969,200 | |
| $149.86 | +2.10 | +1.4% | $150.23 | $151.68 | $148.55 | 9,865,600 | |
| $147.76 | -0.59 | -0.4% | $147.00 | $148.69 | $145.95 | 11,124,700 | |
| $148.35 | -1.19 | -0.8% | $146.72 | $149.01 | $145.75 | 8,067,000 | |
| $149.54 | -3.56 | -2.3% | $149.53 | $152.08 | $149.02 | 8,522,600 | |
| $153.10 | -3.35 | -2.1% | $154.35 | $155.19 | $152.61 | 8,627,600 | |
| $156.45 | +5.79 | +3.8% | $151.00 | $156.92 | $150.66 | 14,005,100 | |
| $150.66 | -1.89 | -1.2% | $150.72 | $151.52 | $149.14 | 15,032,000 | |
| $152.55 | +3.56 | +2.4% | $149.12 | $154.49 | $148.59 | 15,976,200 | |
| $148.99 | -3.21 | -2.1% | $150.78 | $152.52 | $148.52 | 16,204,700 | |
| $152.20 | +17.03 | +12.6% | $146.94 | $153.50 | $144.90 | 32,776,300 | |
| $135.17 | -0.80 | -0.6% | $137.24 | $137.98 | $134.88 | 10,284,200 | |
| $135.97 | +0.13 | +0.1% | $134.95 | $137.17 | $134.55 | 8,477,300 | |
| $135.84 | +0.29 | +0.2% | $134.43 | $135.97 | $133.40 | 6,869,000 | |
| $135.55 | +2.63 | +2.0% | $133.86 | $135.68 | $133.06 | 8,895,200 | |
| $132.92 | +2.50 | +1.9% | $130.25 | $134.06 | $128.91 | 10,447,100 | |
| $130.42 | -0.50 | -0.4% | $129.93 | $132.84 | $129.70 | 6,342,200 | |
| $130.92 | +2.34 | +1.8% | $128.29 | $130.98 | $128.24 | 6,007,600 | |
| $128.58 | +0.21 | +0.2% | $127.84 | $128.75 | $126.68 | 7,347,500 | |
| $128.37 | +0.04 | 0.0% | $130.96 | $131.08 | $127.80 | 7,051,700 | |
| $128.33 | +0.33 | +0.3% | $129.41 | $131.09 | $127.56 | 10,501,900 | |
| $128.00 | +0.23 | +0.2% | $128.46 | $129.99 | $126.22 | 11,816,900 | |
| $127.77 | -2.43 | -1.9% | $129.87 | $131.47 | $126.72 | 11,153,800 | |
| $130.20 | +0.41 | +0.3% | $128.92 | $131.04 | $128.14 | 7,738,800 | |
| $129.79 | -0.57 | -0.4% | $128.20 | $130.21 | $127.25 | 7,832,900 |
- Ticker
- Aquis:6MKD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Aquis
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Merck Opens €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea
Latest earnings call · Oct 29, 2026
Merck & (NYSE:MRK) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 28 slides
Calls
Replays
Merck & (NYSE:MRK) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 9:00 AM ET
Watch TranscriptMerck & (NYSE:MRK) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 9:00 AM ET
Watch TranscriptMerck & (NYSE:MRK) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 9:00 AM ET
Watch Transcript
Latest news
Merck Opens €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea
Oct 29, 2026
Closed $146.33 (+3.8%) on Oct 29, 2026
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2026 Financial Results; Highlights Multiple Milestones Advancing Broad, Diverse Pipeline
Oct 29, 2026
Closed $146.33 (+3.8%) on Oct 29, 2026
KEYTRUDA® (pembrolizumab) as Monotherapy Reduced the Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
Oct 26, 2026
Closed $140.61 (-3.2%) on Oct 26, 2026
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Certain Patients With Advanced or Recurrent Endometrial Cancer
Oct 26, 2026
Closed $140.61 (-3.2%) on Oct 26, 2026
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
Oct 22, 2026
Closed $147.24 (-1.8%) on Oct 22, 2026
Merck Collaborates with NVIDIA, Microsoft and Dawn Health to Develop Novel Support Model for People Living with Rare Tumors
Oct 21, 2026
Closed $149.88 (+1.1%) on Oct 21, 2026
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Oct 21, 2026
Closed $149.88 (+1.1%) on Oct 21, 2026
Inaugurates State-of-the-Art ADVANCE Bioanalytical Facility on West Point, Pennsylvania, Campus
Oct 14, 2026
Closed $145.19 (-1.5%) on Oct 15, 2026
Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors
Oct 13, 2026
Closed $141.98 (-2.4%) on Oct 13, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 28 slides · Oct 29, 2026
Investor Day (October 2026)
Investor day · 27 slides · Oct 26, 2026
Q2 2026 Earnings Presentation
Earnings · 33 slides · Aug 4, 2026
International AIDS Conference (AIDS 2026) Investor Event
Conference · 34 slides · Aug 3, 2026
Merck & Company, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 165 in the last 12 months · 179 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 32 calls with a replay · 32 with a transcript · latest Oct 29, 2026
- Decks
- 98 decks · latest Oct 29, 2026
Where Merck & Company, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:MRK · Home listing | NYSE | United States | USD |
| gettex:6MK | gettex | Germany | EUR |
| BCBA:MRK | BCBA | Argentina | ARS |
| Xetra:6MK | Xetra | Germany | EUR |
| Tradegate:6MK | Tradegate | Germany | EUR |
| BMV:MRK | BMV | Mexico | MXN |
| BCBA:MRKD | BCBA | Argentina | USD |
| B3:MRCK34 | B3 | Brazil | BRL |
| Milan:1MRKX | Milan | Italy | EUR |
| TSX:MRK | TSX | Canada | CAD |
| LS Exchange:A0YD8Q | LS Exchange | Germany | EUR |
| Cboe Canada:MRK | Cboe Canada | Canada | CAD |
| Frankfurt:6MK | Frankfurt | Germany | EUR |
| Lang & Schwarz:A0YD8Q | Lang & Schwarz | Germany | EUR |
| BCS:MRKCL | BCS | Chile | CLP |
| SIX Swiss:MRK.USD | SIX Swiss | Switzerland | USD |
| LSE:0QAH | LSE | United Kingdom | USD |
| BOATS:MRK | BOATS | United States | USD |
| BIVA:MRK | BIVA | Mexico | MXN |
| BCS:MRK | BCS | Chile | USD |
| SIX Swiss:MRK | SIX Swiss | Switzerland | CHF |
| EUROTLX:4MRKX | EUROTLX | Italy | EUR |
| VIE:MRK | Vienna | Austria | EUR |
| BCBA:MRK.B | BCBA | Argentina | ARS |
| BCBA:MRKC | BCBA | Argentina | USD |
| Hanover:6MK | Hanover | Germany | EUR |
| Stuttgart:6MK | Stuttgart | Germany | EUR |
| Dusseldorf:6MK | Dusseldorf | Germany | EUR |
| BSESOF:6MK | BSESOF | Bulgaria | EUR |
| BVL:MRKUS | BVL | Peru | PEN |
| Hamburg:6MK | Hamburg | Germany | EUR |
| Munich:6MK | Munich | Germany | EUR |
| BX Swiss:6MK | BX Swiss | Switzerland | CHF |
| Turquoise:MRKN | Turquoise | United Kingdom | USD |
| Aquis:6MKD · This page | Aquis | United Kingdom | EUR |
| Aquis:6MKD | Aquis | United Kingdom | EUR |
| Frankfurt:6MK0 | Frankfurt | Germany | EUR |
| BCBA:MRK.CI | BCBA | Argentina | ARS |
| SET:MRK03 | SET | Thailand | THB |
Log in to ask 6ix AI your own questions about Merck & Company, Inc.